𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GlycoVis: Visualizing glycan distribution in the protein N-glycosylation pathway in mammalian cells

✍ Scribed by Patrick Hossler; Lin-Tang Goh; May May Lee; Wei-Shou Hu


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
654 KB
Volume
95
Category
Article
ISSN
0006-3592

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Glycosylation has profound effects on the quality of recombinant proteins produced in mammalian cells. The biosynthetic pathways of N‐linked glycans on glycoproteins involves a relatively small number of enzymes and nucleotide sugars. Many of these glycoconjugate enzymes can utilize multiple N‐glycans as substrates, thus generating a large number of glycan intermediates, and making the biosynthetic pathway resemble a network with diverging and converging paths. The N‐glycans on secreted glycoprotein molecules include not only terminal glycans, but also pathway intermediates. To better assess the glycan distribution and the potential route of their synthesis, we created GlycoVis, a visualization program that displays the distribution and the potential reaction paths leading to each N‐glycan on the reaction network. The substrate specificities of the enzymes involved were organized into a relationship matrix. With the input of glycan distribution data, the program outputs a reaction pathway map which labels the relative abundance levels of different glycans with different colors. The program also traces all possible reaction paths leading to each glycan and identifies each pathway on the map. Glycoform distribution of Chinese Hamster Ovary cell‐derived tissue plasminogen activator (TPA), and human and mouse IgG were used as illustrations for the application of GlycoVis. In addition, the intracellular and secreted IgG from an NS0 producer cell line were isolated, and their glycoform profiles were displayed using GlycoVis for comparison. This visualization tool facilitates the analysis of potential reaction paths utilized under different physiological or culture conditions, and may provide insight on the potential targets for metabolic engineering. Β© 2006 Wiley Periodicals, Inc.


πŸ“œ SIMILAR VOLUMES


Engineering N-glycosylation pathways in
✍ Donald L Jarvis; Ziad S Kawar; Jason R Hollister πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 548 KB

The inability to produce eukaryotic glycoproteins with complex N-linked glycans is a major limitation of the baculovirus-insect cell expression system. Recent studies have demonstrated that metabolic engineering can be used to extend the glycoprotein processing capabilities of lepidopteran insect ce

Three putative N-glycosylation sites wit
✍ Phillip L. Quirk; Suma Rao; Bryan L. Roth; Ruth E. Siegel πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 462 KB

The serotonin type 3 A receptor (5-HT3 A R) is a ligandgated ion channel (LGIC) that modulates a diverse set of cognitive and physiological functions. The 5-HT3 A R, as with other LGICs, is a pentameric ion channel comprising five glycoprotein subunits. Although the N-terminal of the 5-HT3 A R conta

N-glycosylation of the Xenopus laevis Cl
✍ Sandra Schmieder; StΓ©phanie Bogliolo; Jordi Ehrenfeld πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 295 KB πŸ‘ 2 views

## Abstract Mutations in the gene encoding ClC‐5 lead to X‐linked hypercalciuric nephrolithiasis (XLHN), characterized by proteinuria, hypercalciuria, and phosphaturia. In renal proximal tubule cells, ClC‐5 was identified as an important player in endocytosis, which ensures reabsorption of filtered

Doxorubicin induces expression of multid
✍ Chie Shinoda; Muneharu Maruyama; Takashi Fujishita; Junichi Dohkan; Hirofumi Oda πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 646 KB

Multidrug resistance (MDR) is a major impediment to successful chemotherapy for lung cancer. Overexpression of multidrug resistance-associated protein 1 (MRP1) appears to be involved in MDR development in lung cancer cells. A number of chemotherapeutic agents including doxorubicin (DOX) were reporte